As of close of business last night, Vera Therapeutics Inc’s stock clocked out at $40.85, down -3.54% from its previous closing price of $42.35. In other words, the price has decreased by -$1.50 from its previous closing price. On the day, 620076 shares were traded.
Ratios:
To gain a deeper understanding of VERA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.42 and its Current Ratio is at 7.42. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On December 18, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on December 18, 2023, with a $29 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 25 ’24 when Katabi Maha sold 340,000 shares for $40.50 per share. The transaction valued at 13,770,000 led to the insider holds 2,793,987 shares of the business.
Katabi Maha sold 413,450 shares of VERA for $16,748,860 on Mar 22 ’24. The Director now owns 3,133,987 shares after completing the transaction at $40.51 per share. On Mar 21 ’24, another insider, Katabi Maha, who serves as the Director of the company, sold 81,009 shares for $44.20 each. As a result, the insider received 3,580,723 and left with 3,547,437 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2.22B and an Enterprise Value of 2.12B.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $50.78, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 40.77, while the 200-Day Moving Average is calculated to be 21.57.
Shares Statistics:
It appears that VERA traded 1.28M shares on average per day over the past three months and 749.25k shares per day over the past ten days. A total of 44.45M shares are outstanding, with a floating share count of 39.27M. Insiders hold about 26.88% of the company’s shares, while institutions hold 61.59% stake in the company. Shares short for VERA as of Mar 15, 2024 were 6.24M with a Short Ratio of 4.88, compared to 6.77M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.62% and a Short% of Float of 14.54%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.53 for the current quarter, with a high estimate of -$0.46 and a low estimate of -$0.6, while EPS last year was -$0.8. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.47 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$1.98 and -$2.62 for the fiscal current year, implying an average EPS of -$2.16. EPS for the following year is -$2.32, with 6 analysts recommending between -$1.85 and -$3.17.
